GPC3 and hepatocellular carcinoma: We established a CTC detection method targeting GPC3, a cell surface marker specific to HCC, and previously reported its clinical utility.9 Consistent with earlier studies,23–33 we demonstrated that CTC positivity was an independent predictor of microscopic PVI.